High-frequency magnetic brain stimulation to improve thinking after stroke
Official title: Efficacy of High-Frequency Repetitive Transcranial Magnetic Stimulation in Patients With Post-Stroke Cognitive Impairment: A Randomized Controlled Trial
Run by Qilu Hospital of Shandong University · NCT07546877 · Data updated 2026-11-12
This study will test whether daily high-frequency (10 Hz) rTMS can improve thinking and memory in adults 35–75 years old who have cognitive problems 1–12 months after a first stroke.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 75 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Qilu Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | July 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | April 23, 2026 |
| Trial ID | NCT07546877 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 35–75 with a first stroke 1–12 months earlier who have cognitive impairment (MoCA < 26, adjusted for education), stable vital signs, and the ability to complete testing are the ideal candidates.
✕Probably not a fit
People with a history of brain tumors or brain trauma, severe communication or sensory impairments, progressive neurological symptoms, or other contraindications to rTMS are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants are randomly assigned to receive either real high-frequency (10 Hz) repetitive transcranial magnetic stimulation (rTMS) or a sham coil that looks and sounds the same but does not produce a magnetic field. Treatment is delivered 20 minutes a day for 20 sessions, with clinical cognitive scales and brain imaging (fNIRS and EEG) recorded before treatment, after 10 sessions, and after 20 sessions. The team uses a double-blind, controlled design so neither participants nor raters know who receives real stimulation. Outcomes focus on changes in cognitive function and brain functional activity measures.
Why it matters
Potential benefit: If successful, the intervention could improve post-stroke cognitive function and offer a non-drug option to help recovery of thinking and daily functioning.
How similar studies have gone: Prior randomized trials of rTMS for post-stroke cognitive problems have shown promising but mixed results, so this approach has some supporting evidence but is not yet definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Meets the diagnostic criteria for stroke as stipulated in the "Guidelines for the Prevention and Treatment of Stroke in China (2021 Edition)", and the initial stroke diagnosis is confirmed by cranial CT or MRI examination, and is confirmed as the initial onset; 2. The disease course is 1-12 months; 3. Has cognitive impairment (MoCA \< 26 points, education years ≤ 12 years, add 1 point to the score result); 4. Age 35-75 years old, gender not limited; 5. Stable vital signs, no progressive neurological symptoms; 6. No severe aphasia, visual or auditory impairment, and able to complete the research protocol; 7. Not using antidepressant drugs simultaneously; 8. If using cognitive-improving drugs (such as donepezil, memantine), it should last for at least 3 weeks or more, and no dose adjustment will be made during the enrollment period; 9. Voluntarily participate and sign the informed consent form. Exclusion Criteria: 1. Has a history of brain tumors, brain trauma, epilepsy or mental disorders; 2. Had cognitive impairment before the stroke; 3. Underwent craniotomy or had a skull defect; 4. Had implanted metal or electronic devices (such as cardiac pacemakers, cochlear implants, deep brain stimulators, aneurysm clips, internal fixation devices after ventriculoperitoneal shunt surgery, etc.); 5. Has other serious diseases that may affect the study; 6. Pregnant women
Where it's running
-
Qilu Hospital of Shandong University
Jinan, China Recruiting
Study contacts
- Study coordinator: Run Sheng
- Email: shengrun2001@163.com
- Phone: 8615069169127
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based cognitive training for people after stroke
This trial will test whether an AI-based mobile app can help adults aged 45–60 improve thinking and memory after a stroke.
-
Immersive virtual reality cognitive rehabilitation for post-stroke cognitive impairment
This pilot will try immersive virtual reality exercises with adults who have cognitive problems after a stroke to see if the approach is feasible, safe, and acceptable during outpatient rehabilitation.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Butyphthalide's effect on cognitive recovery after stroke
This study is testing if a new medication called butyphthalide can help improve thinking and memory in older adults who have had a stroke.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.